UK
The AI-based early warning system the NHS is developing is part of the government's 10 Year Health Plan to use data to identify patient safety concerns.
The function that allows those to claim the support wasn't added to the app.
The high street beauty and health retailer is taking one step further to introduce digital services for its customers.
The firm also announced a deal with a Fortune 200 company to launch gestational diabetes product in the US.
Bauer initially joined LIVI as VP of product earlier this year.
Over 230 measles cases were reported in the UK in the first quarter of the year.
The new service is based on the US Crisis Text Line model.
The German firm will provide pharmaceutical insight in a consortium which aims to accelerate discovery and development of new medicines using clinical AI.
The team hopes the new sensor will enable faster identification of conditions in areas with scarce resources in order to help families and their newborns.
Editor's note: This story has been updated with comments from Cera.